TIP836: Exor NV (EXO): The Massive Discount Continues To Widen w/ Kyle Grieve & Shawn O’Malley
Thursday, 6 August 2026 · 4 min read · Listen to the episode ↗
Kyle Grieve and Shawn O'Malley examine Exor NV, an Italian holding company trading at roughly a 60 percent discount to its net asset value of approximately $193 per share, nearly double its historical average discount of 30 percent. The most striking valuation anomaly is that the market value of Exor's Ferrari stake alone exceeds Exor's entire market capitalization, implying all other holdings carry zero or negative value.
Exor NV is an Italian-listed holding company trading at roughly a 60 percent discount to its net asset value of approximately $193 per share as of mid-2026, compared to a historical average discount of around 30 percent. Shawn O'Malley originally purchased shares at about $86, and they have since fallen further to around $79, meaning the discount has widened rather than narrowed since his entry. The most striking feature of the valuation is that the market value of Exor's Ferrari stake alone exceeds Exor's entire market capitalization, implying all other holdings are being assigned zero or negative value by the market.
Ferrari has compounded at roughly 21 percent annually over the last decade and returned approximately 11 times Exor's invested capital over ten years, making it one of the more remarkable holding company investments in recent memory. Ferrari posted record top- and bottom-line numbers recently but with a decelerating growth rate, which caused the market to compress its multiple from over 57 times earnings in early 2025 to approximately 30 times following weakness in early 2026 and the Luce announcement. Ferrari's five-year guidance implies roughly 5 percent annual revenue growth, well below what a 60 times earnings multiple had previously assumed, which partially justified the sell-off. Grieve's model assumes 1 to 2 percent volume growth per year, 7 percent total revenue growth combining price and volume, operating margins expanding to 30 percent in the terminal year, and low double-digit earnings per share growth for several years. Ferrari's average revenue per unit has grown from approximately $239,000 in 2017 to approximately $446,000, a roughly 5 percent compound annual growth rate, and Grieve argues this pricing power means Ferrari can achieve its revenue targets without meaningful volume increases.
Ferrari's recession resistance is attributed to its waitlist model, where customers risk losing their place in line if they decline a purchase. Revenue declined only about 8 percent during the pandemic, the only year since IPO that revenue did not increase. Approximately 85 percent of Ferrari's roughly 14,000 annual buyers are repeat customers, and the high-value relationship extends well beyond the initial purchase through Ferrari-specialist servicing, customization, and maintenance over a 20 to 30 year ownership cycle. A brake pad replacement at a track event cost approximately $8,000, roughly 15 to 20 times the cost on a normal car.
The Ferrari Luce electric vehicle has been a source of controversy. O'Malley argues EVs are structurally misaligned with Ferrari's brand identity because they prioritize efficiency and practicality, and that battery size prevents achieving the sleek shape and engine performance that justify Ferrari's extreme price points. Former CEO Luca di Montezemolo publicly said the Luce risks destroying a legend. However, actual sales data contradicts the negative narrative. Ferrari allocated approximately 90 Luce units to the Chinese market at roughly $590,000 each, and the allocation sold out within about one month. The Luce order book extends toward the end of 2027, and Ferrari CEO Benedetto Vigna confirmed orders from both existing and new customers. Ferrari has also revised its expected share of electric vehicles in its 2030 lineup down from 40 percent to 20 percent. The Luce is explicitly aimed at attracting a more tech-forward cohort rather than serving the existing base, which O'Malley says is necessary given that total volume has been relatively flat for several years.
The core investment thesis for Exor is simple: if the discount narrows from 60 percent to the historical average of 30 percent, that alone would represent a double independent of any further compounding in the underlying assets. O'Malley acknowledges there is no identified catalyst that would meaningfully close the gap, and Grieve notes that determining when a holding company discount closes is very difficult and may be impossible to forecast. The Prosus situation, where the holding company traded at roughly 80 billion euros while its Tencent position alone was worth 110 billion euros, is cited as a cautionary example where the discount did not close despite being widely pitched in value investing circles for years.
Exor's investment management subsidiary Lingado, established in 2023, manages over $10 billion in assets across four funds and is mentioned 13 times in Exor's latest investor relations deck, up from six mentions in 2025. Its Intersection strategy, focused on concentrated public markets positions, is credited with most of Lingado's returns, which Grieve estimates at approximately 40 percent in 2025 alone. Top disclosed positions include Teva Pharmaceuticals, Carvana, Paramount Skydance, Valaris, and Nova Gold Resources. O'Malley estimates a 1 percent management fee on $10 billion would generate $100 million annually, with a standard 20 percent performance fee potentially adding approximately $240 million based on 2025 performance. Exor recently divested stakes in Ivaco Group, GEDI, LifeNet, and NUO for approximately 2 billion euros at roughly a 1.4 times multiple on invested capital, which Grieve reads as a possible signal that Exor is simplifying and concentrating its holdings.
Kill criteria for the position include poor capital allocation decisions such as skipping buybacks to overpay for mediocre acquisitions, which would validate the market's view that the discount is deserved, and the removal of John Elkann as CEO. Ongoing Agnelli family lawsuits are considered low likelihood to affect control.
This summary was generated from the episode transcript and can contain mistakes.